Follow-On Biologics Debate May Divide PhRMA On Comparability Protocols
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA President Tauzin acknowledges “there’s a little difference of opinion” among membership about what the criteria for interchangeability should be.